Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Nabis Holdings to Acquire 49 Percent of Israeli Cannabis Company Cannova Medical
Error: Contact form not found.
by Adi Pick / CTech
An employee tends to a medical cannabis plants at Pharmocann, an Israeli medical cannabis company in northern Israel, Jan. 24, 2019. Photo: Reuters / Amir Cohen / File.
CTech – Canadian Securities Exchange-listed Nabis Holdings, a Canadian company focused on cannabis investments, will be acquiring a 49 percent stake in Israel-based Cannova Medical, the former announced Monday. Nabis will pay Cannova $1 million and also issue Cannova 5,911,111 common shares of Nabis, according to the company’s statement. Following the acquisition, Nabis will have exclusive distribution rights for Cannova’s product in North America.
Incorporated earlier this year, Cannova develops a strip for oral administration of active cannabis substances, to allow producers to more effectively control dosage quantities and safety in the delivery of cannabinoid products.
